Shares of Similarweb Ltd. (NYSE:SMWB - Get Free Report) have earned an average recommendation of "Buy" from the nine brokerages that are currently covering the stock, MarketBeat.com reports. Eight research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $13.14.
Several research analysts have weighed in on SMWB shares. Northland Securities increased their price target on shares of Similarweb from $15.00 to $17.00 and gave the company an "outperform" rating in a report on Tuesday, November 26th. Needham & Company LLC boosted their price target on Similarweb from $11.00 to $14.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Citigroup boosted their target price on shares of Similarweb from $10.00 to $14.00 and gave the company a "buy" rating in a research report on Thursday, November 14th. William Blair reaffirmed an "outperform" rating on shares of Similarweb in a research report on Monday, September 9th. Finally, Northland Capmk upgraded shares of Similarweb to a "strong-buy" rating in a research report on Tuesday, September 10th.
Check Out Our Latest Stock Report on SMWB
Hedge Funds Weigh In On Similarweb
Institutional investors have recently added to or reduced their stakes in the stock. Public Employees Retirement System of Ohio acquired a new position in shares of Similarweb during the third quarter worth $70,000. Quantbot Technologies LP acquired a new stake in shares of Similarweb during the third quarter valued at about $75,000. ANTIPODES PARTNERS Ltd grew its holdings in shares of Similarweb by 122.5% during the second quarter. ANTIPODES PARTNERS Ltd now owns 11,580 shares of the company's stock worth $90,000 after purchasing an additional 6,376 shares during the last quarter. State of New Jersey Common Pension Fund D acquired a new position in shares of Similarweb in the third quarter valued at approximately $122,000. Finally, Barclays PLC raised its holdings in Similarweb by 201.0% in the 3rd quarter. Barclays PLC now owns 15,414 shares of the company's stock valued at $136,000 after buying an additional 10,293 shares during the last quarter. 57.59% of the stock is currently owned by institutional investors and hedge funds.
Similarweb Price Performance
NYSE SMWB traded down $0.20 on Tuesday, hitting $12.20. 250,184 shares of the stock were exchanged, compared to its average volume of 227,899. The business's fifty day moving average is $10.26 and its 200 day moving average is $8.71. The company has a market capitalization of $987.21 million, a PE ratio of -112.73 and a beta of 1.03. Similarweb has a 52 week low of $4.91 and a 52 week high of $13.41.
About Similarweb
(
Get Free ReportSimilarweb Ltd. provides cloud-based digital intelligence solutions in the United States, Europe, the Asia Pacific, the United Kingdom, Israel, and internationally. The company offers digital research intelligence solutions for its customers to benchmark performance against competitors and market leaders, analyze trends in the market, conduct deeper research into specific companies, and analyze audience behavior; and digital marketing intelligence solutions for its customers to understand their competitors' online acquisition strategies in each marketing channel, and optimize their own strategies.
Featured Articles
Before you consider Similarweb, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Similarweb wasn't on the list.
While Similarweb currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.